OPCH Option Care Health, Inc.
FY2025 10-K
Option Care Health, Inc. (OPCH) filed its fiscal year 2025 10-K annual report with the SEC on Feb 24, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: Largest independent provider of home and alternate site infusion therapy via 196 locations in 43 states, serving complex chronic conditions
- • New emphasis: Expansion of ambulatory infusion suites to 109 standalone locations, including 27 with advanced practitioner capabilities
Management Discussion & Analysis
- • Revenue $5.65B, up 13.0% YoY from $5.00B driven by mid-teens growth in acute therapies and low double-digit chronic growth
- • Operating margin declined to 6.0% from 6.4%; gross margin fell to 19.3% from 20.3% due to therapy mix and biosimilar adoption
Risk Factors
- • No specific or timely risk factors disclosed in provided text
Financial SummaryXBRL
Revenue
$5.6B
Net Income
$208M
Gross Margin
19.3%
Operating Margin
6.0%
Net Margin
3.7%
ROE
15.7%
Total Assets
$3.5B
EPS (Diluted)
$1.27
Operating Cash Flow
$258M
Source: XBRL data from Option Care Health, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Option Care Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.